Showing results (321-330 of 622) with videos related to

Sort By:
Pageof 63
Pathology, Research and Practice|April 27, 2000
T311--an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissuesA A Jungbluth, K Iversen, K Coplan, et al.
The American Journal of Surgical Pathology|January 9, 1998
Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumorsK J Busam, K Iversen, K A Coplan, et al.
Cancer Research|July 26, 2000
Serological cloning of a melanocyte rab guanosine 5'-triphosphate-binding protein and a chromosome condensation protein from a melanoma complementary DNA libraryD Jäger, E Stockert, E Jäger, et al.
Neuroscience|June 4, 2013
Human endogenous retrovirus W family envelope gene activates the small conductance Ca2+-activated K+ channel in human neuroblastoma cells through CREBS Li, Z C Liu, S J Yin, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 22, 2016
[Surgical treatment and prognosis of pancreatic neuroendocrine carcinoma]J W Zhang, X Che, Z M Lan, et al.
Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica|February 24, 2001
Antagonistic effect of l-stepholidine on striatal ischemic injury in ratF M Tang, Y M Ding, Y T Chen, et al.
Cancer Research|January 8, 2000
Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue geneD Jäger, E Stockert, M J Scanlan, et al.
Cancer|October 26, 2012
The impact of dose-escalated radiotherapy plus androgen deprivation for prostate cancer using 2 linked nomogramsRadka Stoyanova, Niraj H Pahlajani, Brian L Egleston, et al.
Gene Therapy|September 10, 2004
Improved efficacy of gene therapy approaches for Pompe disease using a new, immune-deficient GSD-II mouse modelF Xu, E Ding, S X Liao, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 5, 2006
The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA)E S Siris, S K Brenneman, E Barrett-Connor, et al.
Pageof 63